Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
USA- Bluejay Therapeutics has announced the completion of a US$41 million Series B round of financing led by Arkin Bio Ventures. Other new and existing investors in this round include…
Read More
USA – Johnson & Johnson has announced the termination of its collaboration and license agreements with Bavarian Nordic to develop potential vaccines against hepatitis B and human papillomaviruses (HPV). However,…
Read More
JAPAN – Shionogi and NEC Corporation have signed a strategic research collaboration agreement to develop a novel hepatitis B therapeutic vaccine. The two companies will divide responsibilities based on areas…
Read More